Search Result "RO4987655"
Back to the Bench? MEK and ERK Inhibitors for the Treatment of KRAS Mutant Lung Adenocarcinoma
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 5 Year: 2018 Page: 558-574
Author(s): Jens Kohler,Marco Catalano,Chiara Ambrogio
The Therapeutic Promise of Anti-Cancer Drugs Against the Ras/Raf/MEK/ERK Pathway
Ebook: Topics in Anti-Cancer Research
Volume: 2 Year: 2013
Author(s): Erin K. Crane,Kwong-Kwok Wong
Doi: 10.2174/9781608051366113020006
RAS/RAF/MEK Inhibitors in Oncology
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 8 Year: 2012 Page: 1164-1176
Author(s): , M. Broggini
Nanosized Modification Strategies for Improving the Antitumor Efficacy of MEK Inhibitors
Journal: Current Drug Targets
Volume: 21 Issue: 3 Year: 2020 Page: 228-251
Author(s): Yanan Li,Qingrong Dong,Ting Mei,Meichen Zheng,Ramasamy Raj Kumar,Bin Yu,Chunsheng Wu,Hui Zhang,Feifei An
Recent Developments in Targeted Therapies of the RAF-MEK and PI3KAKT Pathways in Cancer Treatment
Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 3 Year: 2012 Page: 205-217
Author(s): Lobke G.M. Cremers,Johannes Boonstra
Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine
Journal: Current Drug Targets
Volume: 16 Issue: 1 Year: 2015 Page: 47-59
Author(s): Simona Coco,Anna Truini,Irene Vanni,Maria Giovanna Dal Bello,Angela Alama,Erika Rijavec,Carlo Genova,Giulia Barletta,Claudio Sini,Giovanni Burrafato,Federica Biello,Francesco Boccardo,Francesco Grossi
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 14 Issue: 3 Year: 2019 Page: 203-225
Author(s): Debora Basile,Camilla Lisanti,Maria A. Pizzichetta,Paolo Baldo,Giulia Fornasier,Francesco Lo Re,Giuseppe Corona,Fabio Puglisi